Skip to main content
. 2013 Sep 30;8(9):e75691. doi: 10.1371/journal.pone.0075691

Figure 4. Sc-KU-4 impairs hemocyte aggregation.

Figure 4

A: Hemolymph stained with peanut agglutinin-FITC conjugated (PNA-FITC) reveal a significant (p < 0.05) less number of aggregates on samples treated with Sc-KU-4 that in control. Also the size of aggregates was significantly (p < 0.05) smaller in treated samples. Magnified boxes highlight activated hemocytes (arrows). B: SEM showing hemocytes aggregated in hemolymph activated with LPS whereas in hemolymph treated with Sc-KU-4, the huge majority of hemocytes remained dispersed. Magnified boxes highlight that hemocytes aggregates formed in the control were trapped in a newly formed matrix but in treated samples were not (arrows). Three independent replicates were done.